Remove Leads Remove Pharmaceutical manufacturing Remove Retail Remove Safety
article thumbnail

Leading patient adherence pharmaceutical companies

Pharmaceutical Technology

Discover the leading patient adherence pharmaceutical companies. Pharmaceutical Technology has listed the top patient adherence pharmaceutical companies based on our intel, insights and decades-long expertise in the sector.

Leads 52
article thumbnail

Leading commercial dose (non-sterile) companies in contract marketing

Pharmaceutical Technology

Contract marketing companies support pharmaceutical companies in creating, improving, and maintaining their brand, as well as reducing risk, and ensuring better product placement in the market. Newly emerging technologies have helped in improving the effectiveness and safety of non-sterile commercial dose products.

Leads 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

PhRMA lies to protect pharma profits

World of DTC Marketing

He leads the Program on Regulation, Therapeutics, and Law at Brigham and Women’s Hospital in Boston. The online retailer spends about $20 billion a year on R&D, despite being renowned for low prices and low profits. And yet, he said, regulatory changes rarely choked out investment in new drugs. It’s Amazon.

Pharma 255
article thumbnail

How one pharma “family business” places patients first

pharmaphorum

The status isn’t awarded lightly and Chiesi is the largest pharmaceutical manufacturer to be named a B Corp. “We We start our meetings by bringing to life a patient testimony and asking the team to reflect on how the goal of each meeting ultimately leads back to the needs of patients,” Chiesi says. “If About the author.

article thumbnail

Drug pricing increases are disgraceful

World of DTC Marketing

The online retailer spends about $20 billion a year on R&D, despite being renowned for both low prices and low profits. About 40 percent of drugs fail in preliminary Phase I studies, which assess a drug’s safety in humans and typically cost just $25 million a drug. It’s Amazon.

Insurance 181